Publications Search

Search for publications by author
Search for publications by abstract keyword(s)

Search results

52 items matching your search terms.
Emerging data and future directions for CDK4/6 inhibitor treatment of patients with hormone receptor positive HER2-non-amplified metastatic breast cancer
Lim, E.; Beith, J.; Boyle, F.; de Boer, R.; Hui, R.; McCarthy, N.; Redfern, A.; Wade, T.; Woodward, N.
Asia-Pacific Journal of Clinical Oncology 14 Suppl 4 :12-21, 2018 10.1111/ajco.13065
Assessment and management of bone health in women with oestrogen receptor-positive breast cancer receiving endocrine therapy: Position statement of the Endocrine Society of Australia, the Australian and New Zealand Bone & Mineral Society, the Australasian Menopause Society and the Clinical Oncology Society of Australia
Grossmann, M.; Ramchand, S. K.; Milat, F.; Vincent, A.; Lim, E.; Kotowicz, M. A.; Hicks, J.; Teede, H.
CLINICAL ENDOCRINOLOGY 89 (3) :280-296, 2018 10.1111/cen.13735
OpenAccess publication Targeting stromal remodeling and cancer stem cell plasticity overcomes chemoresistance in triple negative breast cancer
Cazet, A. S.; Hui, M. N.; Elsworth, B. L.; Wu, S. Z.; Roden, D.; Chan, C. L.; Skhinas, J. N.; Collot, R.; Yang, J.; Harvey, K.; Johan, M. Z.; Cooper, C.; Nair, R.; Herrmann, D.; McFarland, A.; Deng, N.; Ruiz-Borrego, M.; Rojo, F.; Trigo, J. M.; Bezares, S.; Caballero, R.; Lim, E.; Timpson, P.; O'Toole, S.; Watkins, D. N.; Cox, T. R.; Samuel, M. S.; Martin, M.; Swarbrick, A.
Nature Communications 9 (1) :2897, 2018 10.1038/s41467-018-05220-6
OpenAccess publication A quantitative mass spectrometry-based approach to monitor the dynamics of endogenous chromatin-associated protein complexes
Papachristou, E. K.; Kishore, K.; Holding, A. N.; Harvey, K.; Roumeliotis, T. I.; Chilamakuri, C. S. R.; Omarjee, S.; Chia, K. M.; Swarbrick, A.; Lim, E.; Markowetz, F.; Eldridge, M.; Siersbaek, R.; D'Santos, C. S.; Carroll, J. S.
Nature Communications 9 (1) :2311, 2018 10.1038/s41467-018-04619-5
Attitudes of patients with metastatic cancer towards research biopsies
Robinson, D. H.; Churilov, L.; Lin, N. U.; Lim, E.; Seah, D.
Asia-Pacific Journal of Clinical Oncology 14 (3) :231-238, 2018 10.1111/ajco.12783
Microenvironmental control of breast cancer subtype elicited through paracrine platelet-derived growth factor-CC signaling
Roswall, P.; Bocci, M.; Bartoschek, M.; Li, H.; Kristiansen, G.; Jansson, S.; Lehn, S.; Sjolund, J.; Reid, S.; Larsson, C.; Eriksson, P.; Anderberg, C.; Cortez, E.; Saal, L. H.; Orsmark-Pietras, C.; Cordero, E.; Haller, B. K.; Hakkinen, J.; Burvenich, I. J. G.; Lim, E.; Orimo, A.; Hoglund, M.; Ryden, L.; Moch, H.; Scott, A. M.; Eriksson, U.; Pietras, K.
NATURE MEDICINE 24 (4) :463-473, 2018 10.1038/nm.4494
OpenAccess publication Vinorelbine potently induces placental cell death, does not harm fertility and is a potential treatment for ectopic pregnancy
Hastie, R.; Lim, E.; Sluka, P.; Campbell, L.; Horne, A. W.; Ellett, L.; Hannan, N. J.; Brownfoot, F.; Kaitu'u-Lino, T. J.; Tong, S.
EBioMedicine 29 :166-176, 2018 10.1016/j.ebiom.2018.01.041
Secreted tumor antigens - immune biomarkers for diagnosis and therapy
Meeusen, E. N.; Lim, E.; Mathivanan, S.
PROTEOMICS 17 (23-24) :1600442, 2017 10.1002/pmic.201600442
Neoadjuvant interferons: critical for effective PD-1 based immunotherapy in TNBC
Brockwell, N. K.; Owen, K. L.; Zanker, D.; Spurling, A.; Rautela, J.; Duivenvoorden, H. M.; Baschuk, N.; Caramia, F.; Loi, S.; Darcy, P. K.; Lim, E.; Parker, B. S.
Cancer Immunology Research 5 (10) :871-884, 2017 10.1158/2326-6066.CIR-17-0150
The innate and adaptive infiltrating immune systems as targets for breast cancer immunotherapy
Law, A. M.; Lim, E.; Ormandy, C. J.; Gallego-Ortega, D.
ENDOCRINE-RELATED CANCER 24 (4) :R123-R144, 2017 10.1530/ERC-16-0404
OpenAccess publication Sensitizing HR-proficient cancers to PARP inhibitors
Lim, E.; Johnson, S. F.; Geyer, M.; Serra, V.; Shapiro, G. I.
MOLECULAR & CELLULAR ONCOLOGY 4 (6) :e1299272, 2017 10.1080/23723556.2017.1299272
The role of MDM2 and MDM4 in breast cancer development and prevention
Haupt, S.; Vijayakumaran, R.; Panimaya, J.; Burgess, A.; Lim, E.; Haupt, Y.
Journal of Molecular Cell Biology 9 (1) :53-61, 2017 10.1093/jmcb/mjx007
OpenAccess publication Pushing estrogen receptor around in breast cancer
Lim, E.; Tarulli, G.; Portman, N.; Hickey, T.; Tilley, W. D.; Palmieri, C.;
OpenAccess publication Adjuvant endocrine therapy in women with oestrogen-receptor-positive breast cancer: how should the skeletal and vascular side effects be assessed and managed?
Ramchand, S. K.; Lim, E.; Grossmann, M.;
CLINICAL ENDOCRINOLOGY 85 (5) :689-693, 2016
OpenAccess publication CDK12 Inhibition Reverses De Novo and Acquired PARP Inhibitor Resistance in BRCA Wild-Type and Mutated Models of Triple-Negative Breast Cancer
Johnson, S. F.; Cruz, C.; Greifenberg, A. K.; Dust, S.; Stover, D. G.; Chi, D.; Primack, B.; Cao, S.; Bernhardy, A. J.; Coulson, R.; Lazaro, J. B.; Kochupurakkal, B.; Sun, H.; Unitt, C.; Moreau, L. A.; Sarosiek, K. A.; Scaltriti, M.; Juric, D.; Baselga, J.; Richardson, A. L.; Rodig, S. J.; D'Andrea, A. D.; Balmana, J.; Johnson, N.; Geyer, M.; Serra, V.; Lim, E.; Shapiro, G. I.;
Cell Reports 17 (9) :2367-2381, 2016
OpenAccess publication Renewed interest in the progesterone receptor in breast cancer
Lim, E.; Palmieri, C.; Tilley, W. D.;
British Journal of Cancer 115 (8) :909-911, 2016